Answers are grounded in this paper and cite their sources.
Lost in the global burden of obesity, lipedema is a common form of lipodystrophy that affects (cid:1) 10% of women [1]. Lipedema, which is often confused with lymphedema, is characterized by the accumulation of painful, asymmetrical subcutaneous adipose tissue in the lower and upper extremities. Clinical presentation of lipedema is associated with symmetrical swelling, tenderness, easy bruising, and a disproportion between the upper and lower body [1]. Lipedema progresses through four stages, beginning with soft, smooth skin and slight enlargement of affected areas in Stage 1. In Stage 2, the skin presents with palpable nodules with an uneven texture, and fibrosis begins to develop. Stage 3 is marked by significant painful enlargement, lobular formations, and increased tissue fibrosis, leading to mobility issues. By Stage 4, known as lipolymphedema, there is severe fat deposition with lymphatic impairment, causing extensive swelling, hardening of tissues, and functional limitations. A deeper understanding of the molecular underpinnings of lipedema is crucial to distinguishing it from obesity, as its progressive nature and distinct pathophysiology are often overlooked, leading to frequent misdiagnosis and inadequate treatment. In affected areas, adipose tissue is structurally distinct from nonaffected areas in patients with lipedema. These features range from increased adipocyte size, macrophage infiltration, and increased cell proliferation
No takes yet. Share an insight, caveat, or question.
Timothy D. Allerton (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: